Lymph nodes now optional

Area of Science:

• Immunology
• Cancer Biology
• Cell Biology

Background:

• Tertiary lymphoid structures (TLS) are transient immune aggregates that form in non-lymphoid tissues during inflammation and infection.
• TLS presence in tumors is associated with improved patient prognosis and response to immunotherapy.
• The cellular players and mechanisms driving TLS formation in the tumor microenvironment remain incompletely understood.

Purpose of the Study:

• To investigate the role of specific immune cells in orchestrating tertiary lymphoid structure formation within tumor tissues.
• To identify the subset of dendritic cells responsible for initiating and organizing TLS development in the tumor microenvironment.

Main Methods:

• Utilized single-cell RNA sequencing and spatial transcriptomics to analyze immune cell populations and their interactions within tumor tissues.
• Employed flow cytometry and immunohistochemistry to identify and characterize dendritic cell subsets and their localization relative to TLS.
• Conducted in vivo experiments using mouse tumor models to assess the impact of depleting specific dendritic cell subsets on TLS formation.

Main Results:

• Identified a distinct subset of dendritic cells characterized by specific surface markers and gene expression profiles that are enriched within tumor-associated TLS.
• Demonstrated that these dendritic cells actively recruit and interact with other immune cells, including T cells and B cells, to promote TLS organization.
• Showed that depletion of this specific dendritic cell subset significantly impairs TLS formation and reduces anti-tumor immune responses in vivo.

Conclusions:

• A specific subset of dendritic cells plays a critical orchestrating role in the formation of tertiary lymphoid structures within tumor tissues.
• Targeting these dendritic cells may represent a novel therapeutic strategy to enhance anti-tumor immunity by modulating TLS formation.